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Summary This is a case of a thrombo-occlusion occurring below an inferior vena
cava (IVC) ﬁlter inserted in a patient with polycythemia vera and deep vein throm-
bosis. The patient was a 48-year-old man with polycythemia vera and a chief
complaint of swelling, redness, and bursting pain in his right leg. After admis-
sion, contrast-enhanced computed tomography scanning demonstrated a pulmonary
artery thrombus and deep vein thrombosis. We inserted a Gunther tulip vena cava
ﬁlter on day 1 for the prevention of pulmonary embolism (PE), and started anticoag-
ulation therapy based on the guideline of the Japanese Circulation Society for DVT.
In addition to intravenous anticoagulants, we started therapeutic phlebotomy to
improve the hypercoagulability state. On day 4, our patient complained of back pain
caused by thrombo-occlusion below the IVC ﬁlter, despite the anticoagulation ther-
apy and two therapeutic phlebotomies. From this case, we concluded it is important
to lower hemoglobin level and hematocrit as early as possible for IVC-ﬁlter-insertion
in patients with polycythemia vera.
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ntroductionhe incidence of deep vein thrombosis (DVT) and
ulmonary embolism (PE) has been increasing year
y year because of the aging of Japanese soci-
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ty and westernization of life styles. In addition,
ncreased knowledge of these diseases and their
iagnoses has also been a factor. Although the inser-
ion of an inferior vena caval (IVC) ﬁlter in patients
ith DVT has been effective in preventing PE, com-
lications have been reported, including migration
f the ﬁlter, recurrence of PE, ﬁlter occlusion and
xtensive IVC thrombosis. According to an article
ublished in 2005, in patients with polycythemia
era, the incidence of fatal PE was 0.4%, the inci-
gy. Published by Elsevier Ireland Ltd. All rights reserved.
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SFigure 1 (A) Contrast-enhanced computed tomography
thrombus (up-pointing arrow). (B) Defect in right femora
dence non-fatal PE was 0.8%, and the incidence of
DVT was 2.3% in observation of average 2.7 years
of patients with polycythemia vera [1]. We present
the case of a patient with polycythemia vera, a rel-
atively rare myeloproliferative disorder, who was
treated at our hospital for DVT and PE. The IVC ﬁl-
ter inserted in the patient became occluded despite
adequate anticoagulant medications. We suspect
the IVC ﬁlter occlusion was related to the hyper-
coagulation state caused by polycythemia vera.
Case
A 48-year-old man who had been living with poly-
cythemia vera since 2004 presented to our hospital
on October 31, 2007. One week previously, he
noticed that his right leg tired more quickly than
usual when walking. He consulted the department
of hematology in our hospital because of swelling,
redness, and bursting pain in his right leg. Upon
admission, contrast-enhanced computed tomogra-
phy scanning showed a right pulmonary artery
thrombus and a thrombus from the right femoral
vein to the popliteal vein (Fig. 1). Consequently, he
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Figure 2 There is no defect evident above the IVC ﬁlter (1—–
IVC ﬁlter (2—–up-pointing arrow) indicating a thrombo-occlusiafter IVC ﬁlter insertion shows a right pulmonary artery
n indicating deep vein thrombosis (up-pointing arrow).
as referred to the department of cardiology for
he purpose of IVC ﬁlter insertion.
He had a blood pressure of 142/100mmHg, a
eart rate of 95 beats/min, and a body temperature
f 36.1 ◦C. On physical examination, his height was
64 cm with a weight of 61 kg. His palpebral con-
unctiva was hyperemic with normal lung and heart
ounds. There was swelling, redness, and burst-
ng pain in his right leg and the so-called Homans
ign was positive. An arterial blood gas analysis
evealed pH of 7.417, pCO2 of 44.9mmHg, pO2
f 74.9mmHg, and base excess of 3.5mequiv./L.
blood count revealed polycythemia (hemoglobin
evel: 21.4 g/dl; hematocrit: 64.7%). Except for
levations in liver enzymes (aspartate aminotrans-
erase: 38 IU/l; lactic dehydrogenase: 251 IU/l),
-reactive protein (8.41mg/dl), plasma D-dimer
3.6g/ml) and ﬁbrin degradation product (FDP)
10.2g/ml), chemistry values were normal. Coag-
lation studies showed normal levels of protein
antigen, protein C activation, and antithrom-in III. Lupus anticoagulant was also negative.
he echocardiogram showed no right atrium
ilation, tricuspid regurgitation, or pulmonary
ypertension.
up-pointing arrow), but a defect can be seen below the
on. That was suggestive of the IVC ﬁlter occlusion.
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Figure 3 On day 1, we began a continuous intravenous infusion of 15,000 IU/day heparin, adjusting the dose of heparin
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(ccording to the APTT (target APTT: 1.5—2.0 times as lon
00ml each), in addition to anticoagulation therapy, hem
onsequently, the patient complained of back pain on da
emoglobin and D-dimer levels.
We inserted a Gunther tulip IVC ﬁlter via the
ugular vein in the lower section of the renal vein to
revent fatal pulmonary embolism on the ﬁrst day.
imultaneously with IVC ﬁlter insertion, we began
continuous intravenous infusion of 15,000 IU/day
eparin and 3.0mg warfarin. We adjusted the
ose of heparin according to the activated partial
hromboplastin time (APTT) (target APTT: 1.5—2.0
imes as long as control value), and the dose of
arfarin according to an international normalized
atio of 2—3. We also explored the possible causes
o
w
t
t
igure 4 Lung ventilation—perfusion scintigraphy on day 7
up-pointing arrow). That was suggestive of PE.control). In spite of phlebotomizing twice (days 1 and 2,
bin level remained high and the D-dimer level increased.
Removing whole blood three more times decreased the
f the DVT and PE. For example, there were several
xaminations for malignant tumors and hereditary
hrombophilia, but these precipitating causes could
ot be found. Despite anticoagulation based on the
uideline of the Japanese Circulation Society for
VT and 2 therapeutic phlebotomies (days 1 and
), the patient complained of right-sided back pain
n the fourth day (at that time, hemoglobin level
as 19.3 g/dl, hematocrit was 55.3%). With regards
o this symptom, a contrast-enhanced computed
omography scan showed thrombo-occlusion below
showed ventilation—perfusion mismatch in right lung
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the IVC ﬁlter to the right popliteal vein and left
common iliac vein (Fig. 2). The symptoms of his
right leg (swelling, redness, pain) worsened day
by day and ﬁnally he had difﬁculty walking. He
had mild symptoms in the left leg. We consid-
ered performing catheter-directed thrombolytic
therapy, but continuous intravenous and oral
anticoagulation therapy gradually improved his
symptoms. Therapeutic phlebotomy was performed
3 more times (days 6, 7, and 8). His right leg pain
improved little by little, although swelling of the
leg remained. Further coagulation studies showed
the D-dimer and FDP levels decreasing (Fig. 3).
The ventilation—perfusion scanning revealed a
pulmonary embolism on day 7 (Fig. 4). We placed
him on oral anticoagulant therapy and discharged
him on December 5, 2007.
Discussion
Greenﬁeld suggested the indications for IVC ﬁlters
in patients with DVT were anticoagulant con-
traindications, recurrent embolism, anticoagulant
complications, and prophylaxis after embolectomy
[2], but now the indications for their use are
increasing. Several researchers have reported that
the insertion of IVC ﬁlters signiﬁcantly reduced
further pulmonary emboli [3], and the efﬁcacy of
their use is being assessed now.
We believe, in our case, we were also able
to prevent potentially fatal pulmonary emboli,
because ventilation—perfusion scanning after
IVC ﬁlter placement showed only a small pul-
monary embolism. Virchow explained a theory
with three factors delineating the pathogenesis of
venous thrombosis, the so-called Virchow’s triad:
alterations in blood ﬂow, endothelial injury, and
alterations in the constitution of the blood. In our
case, despite anticoagulation therapy based on the
guideline of the Japanese Circulation Society for
DVT after IVC ﬁlter placement, our patient suffered
from thrombo-occlusion below the IVC ﬁlter, caused
by thrombotic tendency associated with viscosity
rise of the blood secondary to polycythemia vera
and reduced blood ﬂow due to a thrombus caught
in the IVC ﬁlter. He complained of back pain caused
by IVC occlusion on the fourth day despite two ther-
apeutic phlebotomies after the IVC-ﬁlter insertion.
The importance of adequate anticoagulation
therapy after IVC ﬁlter placement has been
[
Available online at www.sH. Muranishi et al.
mphasized [4], and two researchers state that
mprovement of viscosity of the blood by therapeu-
ic phlebotomy might prevent thrombo-occlusion
5,6]. In their cases, hematocrit was 51.4% [5] and
9.1% [6] after therapeutic phlebotomies. Addi-
ionally, it has been considered that, in patients
ith polycythemia vera before surgery, lowering
he hematocrit value below 55% by phlebotomiz-
ng reduces the risk of surgery [7,8]. But we
ere able to lower hematocrit only to 55.3%
y therapeutic phlebotomies and suspected that
hrombo-occlusion below the IVC ﬁlter was caused
y insufﬁcient phlebotomizing. From the out-
ome of our case, we concluded it may be
mportant to lower hemoglobin level and hema-
ocrit as early as possible when needing to
nsert an IVC-ﬁlter in a patient with polycythemia
era.
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